by They provide healthcare practitioners with crucial insights into a patient’s cardiovascular health. Advantages of sphygmomanometers include their ease of use, affordability, and ability to monitor blood pressure from the convenience of home. With conditions like hypertension posing a growing health threat worldwide, the need for accurate and accessible blood pressure monitoring has never been more important.
The global sphygmomanometer market is estimated to be valued at US$ 3.92 billion in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period of 2024 to 2031.
Factors such as the rising geriatric population, increasing prevalence of cardiovascular diseases, and growing adoption of home healthcare are expected to drive market revenue higher over the coming years.
Key Takeaways
Key players operating in the sphygmomanometer market include Omron Healthcare, ICU Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, AD Medical, Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International Ltd., PAUL HARTMANN, BPL Medical Technologies, and Homedics. Among these, Omron Healthcare dominates the market with its wide array of clinically-validated digital blood pressure monitors for home use.
The growing prevalence of hypertension and other cardiovascular diseases worldwide is fueling increased demand for Sphygmomanometers Market Demand. Population-wide screening and regular monitoring are becoming increasingly important for the management of chronic conditions. Sphygmomanometers allow for convenient self-monitoring that is less disruptive than visiting a clinical setting.
The integration of telehealth with sphygmomanometers is enabling further expansion of the global market. Remote monitoring capabilities allow patients to digitally transmit blood pressure readings to their healthcare providers, who can track stats over time and respond swiftly to changes. This model of care supports continued access and improved health outcomes while reducing infection risk.
Market Key Trends
One of the major trends gaining traction in the sphygmomanometer market is the growing popularity of wearable, ambulatory blood pressure monitors. These innovative devices can be worn during all waking hours to take periodic readings in real-world settings. By capturing blood pressure variations throughout the day, they provide clinicians with more robust data to aid diagnosis and treatment compared to single-use devices. Additional trends include increasing demand for oscillometric blood pressure monitors that do not require manual inflation/deflation and greater research into home health devices integrated with AI assistants for medication reminders, alerts, and tele-visit capabilities.
Porter’s Analysis
Threat of new entrants: Sphygmomanometer market requires technical expertise in quality assurance and precision manufacturing. Established brands have significant brand loyalty which makes difficult for new entrants.
Bargaining power of buyers: Large healthcare organisations have significant bargaining power as they can negotiate on bulk purchase prices. Individual consumers have low bargaining power.
Bargaining power of suppliers: Major components like mercury, aneroid mechanisms, inflation bladders have few specialized global suppliers resulting in their strong bargaining power.
Threat of new substitutes: Though digital variants are emerging but aneroid sphygmomanometers still have preference in developing regions due to affordability. No significant substitute threat yet.
Competitive rivalry: Presence of global brands and availability of cost effective local variants from Asian markets have increased competition. Players differentiate through innovation in design, accuracy and connectivity.
Geographical Regions
North America region accounted for over 35% of global sphygmomanometer market value in 2024 led by stringent monitoring practices in US and availability of technologically advanced products. Growing awareness about hypertension and expanded medicare coverage are other key growth drivers in the region.
Asia Pacific region projected to witness fastest value CAGR of 11.2% during forecast period. China, India and other Asian countries offer immense opportunities due to rising healthcare investments, growing middle class and prevalence of lifestyle diseases. Local manufactures cater to price sensitive demand through inexpensive yet good quality products.
Europe ranks second in terms of value share led by Germany, UK and France. Presence of prominent players and availability of reimbursement for blood pressure monitoring devices propels the regional market. However, market growth may get impacted due to stringent regulatory approvals for new entrants.
Latin America and Middle East & Africa emerged as high potential markets but require investments in healthcare infrastructure and diagnostic capabilities to realize full potential. Public-private partnerships can play a key role in improving penetration in these regions.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
